Effect of oral contraceptive pills on some serum lipid and electrolyte levels in women with haemoglobin genotypes AA and AS

Medical Science Research

Volumn 28, Issue 1, 2000, Pages 9-11

  Uadia, P O ^a,b   Famodu, A A ^a   Emokpae, Ma ^b  

^a Department of Biochemistry ^*  (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Electrolytes; Haemoglobin AA; Haemoglobin AS; Oral contraceptive pills

Indexed keywords

CALCIUM; CHOLESTEROL; ETHINYLESTRADIOL PLUS NORGESTREL; HEMOGLOBIN; HEMOGLOBIN S; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; POTASSIUM; SODIUM; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROLYTE BLOOD LEVEL; FEMALE; GENETIC ANALYSIS; GENOTYPE; HEMOGLOBIN ANALYSIS; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; POTASSIUM BLOOD LEVEL; RISK ASSESSMENT; SODIUM BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033753914     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Davanzo J, Allan AP, Folge HW. Health consequences of contraceptive use and reproductive pattern. JAMA 1991; 265:2692-2696.
2. Massafra C, Butini P, Cavion MA, Minuto SM, Colombini G. Evaluation of risk of thrombosis during use of low-dose ethinylestradiol-desogestrel oral contraceptive. Adv Contracept 1993; 9:195-203.
3. Kjos SL, Gregory K, Henry AO, Collins C. Evaluation of routine diabetes and lipid screening after age 35 in candidates for or current users of oral contraceptives. Obstet Gynaeco 1993; 82:925-930.
4. Hammond CB, Maxson WS. Modem trends In infertility and contraception control, Vol. 3. Chicago: Year Book Medical Publishers Inc; 1985. pp. 95-112.
5. Araba AB. A survey of haematological variables in 600 healthy Nigerians. Nig Med J 1976; 6:49-53.
6. Ukoli FAM, Adedeji MO, Reid HL. The prevalence of anaemia among school children in Benin City, South Western Nigeria. Health Hyg 1988; 9:103-106.
7. Ononogbu 1C, Oguike SO. ABO blood group, sickle cell trait and serum cholesterol. Clin Chem News 1982; 2:47-49.
8. Oforofuo IAO, Adedeji MO. Effect of sickle cell gene expression on plasma cholesterol in a Nigerian population. Clin Biochem 1994; 27:505-508.
9. Friedewald WT, Levy RT, Frederickson DS. Estimation of concentrations of low density lipoprotein cholesterol in plasma without use of preparative centrifuge. Clin Chem 1972; 18:499-502.
10. Zollner N, Kirsch K. Colourimetric estimation of total lipid in biological systems. Z Ces Exp Med 1962; 135:546-548.
11. Starter RBC, Chauhan PUS. Colourimetric estimation of calcium. Anal Biochem 1967; 20:55-56.
12. Wallace RB, Tamir I, Heis G, Rifkind BM, Christensen B, Glueck CJ. Plasma lipids, lipoproteins and blood pressure in female adolescents using oral contraceptives. J Pediat 1979; 95:1055-1059.
13. Famodu AA, Ehigiegba AE, Fakoya TA, Adeyi J, Diejomaoh FME. Effects of oral contraceptive on fibrinogen levels in African women. Haematologia 1991; 24:135-138.
14. Famodu AA. Serial changes in plasma fibrinogen concentration and fibrinolytic activity in African women on oral contraceptive pills (OCP). Afr J Repr Health 1977; 1:60-66.
15. Famodu AA, Erhunmwunse RU, Elom EU. Fibrinolytic activity in women on oral contraceptive pills: variation due to haemoglobin. Acta Tropica 1992; 52:135-138.
16. Allison AC. The distribution of sickle cell trait in East Africa and elsewhere and its apparent relationship to the incidence of subtertian malaria. Trans R Soc Trop Med Hyg 1954; 48:312-318.
17. Uadia PO. Humoral immune response to Plasmodium falciparum circumsporozoite protein in subjects with AA, AS, SS haemoglobin genotypes. Nig J Physiol Sei 1995; 11:50-52.